Wellington Management Group LLP Apellis Pharmaceuticals, Inc. Call Options Transaction History
Wellington Management Group LLP
- $503 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
285Shares Held
124MCall Options Held
921KPut Options Held
761K-
Avoro Capital Advisors LLC New York, NY12.2MShares$292 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$284 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$243 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$230 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$139 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.63B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...